Buy out

message boards on dsi buy out seem to be heating up with merck, bms and az as leading contenders, interest in oncology drugs seems to be driver and also reports of a merger with takeda

 

Thier due diligence efforts will squash any buyouts. DSI RD= equals average drugs 4 years too late! That includes our male Onc portfolio... Buying us is akin to buying a Raging case of the Clap!

 

Oh no! Sure hope not !

 

Stock has been moving up as they release more data and lots of positive reports from investor groups have come out and so many companies need to merge or buy to survive

 

no one is buying this Shit hole after they do their due diligence. This place is done. Congrats Kk and RL. You drove it into the hound but you both fuked your way thru som tough times. Rob. You are by far the worst person I have ever reported to. How you have the job you do is beyond me. You screwed EE. The one in FL and now in house. Shame on you. What you and KK have done to this place is sad. Barrett would have saved it. The Japanese bought your crap. How, is beyond me but two presidents in a row. Time to go. You have both proven you point fingers and take no true accountability. Rob when you talk be careful who is in the room. You stupid man. Don’t admit to essentially being an idiot. The wall will be falling soon.

 

BARRETT LMAO YOU ARE DELUSIONAL

 

No one in their right mind buys this place. Small oncology company is what DSI will be no thanks to a lucky buy in AR.

 

look at the stock price now! buy out is coming!!!!

 

People and companies, especially Merck, BMS, and AZ, only buy things of value. Where is the value in DSI's onc portfolio? Stop reading the financial trade rags as they have nothing to do with the science of the products. Instead read thoroughly about the consistent failures to meet endpoints of the onc portfolio. The closest thing DSI has is an AML drug whose research has been extended due to less than robust results. Add to it that every company has an AML product in their pipeline, and if it comes out DSI will be 4-6 to market. The second closest thing DSI has is for the rare disease of TGCT which the FDA and DSMB halted enrollment of any new patients in the trials due to a non-fatal toxic liver signal. Breast cancer drug?...5-10 years out. Wake up and get out or remain and let the company decide your fate for. The choice is yours, you just have to take make it and not let someone else dictate it to you.

 

So true...get out or let company decide. I'm looking and so is my manager!

 

Gota get your facts right, AML trial is nearly done and may file in April the TGCT trial is also done and talks are in place with agency and breast cancer is 2021 and don't read trade papers? You think people moving billions of investment dollars don't know what their doing, get a clue you wrote like you k ow what your taking about and clearly you don't



UOTE="anonymous, post: 5986440"]People and companies, especially Merck, BMS, and AZ, only buy things of value. Where is the value in DSI's onc portfolio? Stop reading the financial trade rags as they have nothing to do with the science of the products. Instead read thoroughly about the consistent failures to meet endpoints of the onc portfolio. The closest thing DSI has is an AML drug whose research has been extended due to less than robust results. Add to it that every company has an AML product in their pipeline, and if it comes out DSI will be 4-6 to market. The second closest thing DSI has is for the rare disease of TGCT which the FDA and DSMB halted enrollment of any new patients in the trials due to a non-fatal toxic liver signal. Breast cancer drug?...5-10 years out. Wake up and get out or remain and let the company decide your fate for. The choice is yours, you just have to take make it and not let someone else dictate it to you.[/QUOTE]

 

tbis is all publicly available, AML first approval is expected around March 2019 and 8201 Breast is expected 2020 or 2021 with additional line indications, lung cancer and gastric. all available on line and on our web. TGCT is unknown but high need.
Also the team developing Oncology is new and weren't involved in any of the early failed Oncology products. investor interest has increased and the stock price has improved, a little research would help those who visit this site

 

Foreals?

 

There is a lot of value inowning a company with a strong presence in Asia. That being said DS US will likely go bye bye.

 

looks like someone is ambien typing again. 03:15

 

Or maybe they work in Japan where 3:15 AM is 4:15 PM. But it would be a stretch to think that the person who wrote the ambien comment has a clue that DSI is a Japanese company.

 

or maybe the person writing the ambien comment was referring to the horrible typing and referenced ambien. the poster didn't even mention DSI you dumb fuck

 

Back at ya! It’s a DSI thread!!

 

Back at ya! It’s a DSI discussion board. I don’t need to use foul language and belittle people. You should get therapy for your anger and maybe an ambien so you can get a better nights sleep. You could use it. Now calm down and if you can’t really add to the content of the discussion go bother some other post!

 

no bother no one here nancy boy, try the shredded wheat large bowel drops